Skip to main content

Weather Alert

Hurricane Helene is severely impacting Quest locations across the Southeast. We ask that patients please double check your appointment status to ensure your designated Patient Service Center is operational.

Hide
Quest Diagnostics

Dysregulated Erythroid Mg 2+ Efflux in Type 2 Diabetes

Dysregulated Erythroid Mg 2+ Efflux in Type 2 Diabetes

Authors: Ferreira A, Rivera A, Wohlgemuth JG, Dlott JS, Snyder LM, Alper SL, Romero JR.

Front Cell Dev Biol. 2022 Apr 4;10:861644. doi: 10.3389/fcell.2022.861644. eCollection 2022.

Specialties: Cardiology, Endocrinology, Oncology

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.